|
|
 |
|
Viewing report
|
|
|
|
2010 Trendology: U.S. Pharmaceutical Preparations Manufacturing
Trendology Research, April 2010, Pages: 59
The 2010 Trendology report on the U.S. Pharmaceutical Preparations Manufacturing industry characterizes the industry in three descriptive methods: qualitative analysis, quantitative data and lists of major industry players. The written analysis includes financial issues, technology issues, human resources issues, supplier issues, consumer issues, government regulations, global factors, major industry news highlights, major earnings and profit reports, major mergers and acquisitions, and our exclusive industry SWOT analysis (industry internal strengths, internal weaknesses, external opportunities and external threats). Along with the trend analysis, quantitative data includes five-year trends (2007-2011) on number of establishments, industry and number of employees. This data is developed through Trendology's economic model using regression analysis based on historical industry trend data. Forecasts are available for 2011. Quantitative data for current year 2010 is provided for the U.S., 50 U.S. states, and 900 metro areas. The report also lists up to ten of the industry's major players, their current sales and stock symbol (for public companies). Color charts and graphs run throughout the report to highlight trends and are ready for presentations and displays. Links to Internet sources in the report are useful for additional research and data gathering.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
2011 Trendology: U.S. Pharmacies & Drug Stores
2009 Trendology: U.S. Pharmaceutical Preparations Manufacturing
Contract Research Annual Review 2011
Biosimilars Approval Pathways in the US and Europe - Development and Approval of Biosimilar mABs May Face Tough Regulatory Environment
Truck Bedliners - Global Strategic Business Report
Human Vaccines - Global Strategic Business Report
Therapeutic Apheresis - A US Market Report
Nuclear Medicine - Global Strategic Business Report
Regenerative Medicine - Global Strategic Business Report
Impact of US Healthcare Reforms - the Extension of Care to 32 Million Uninsured Citizens from 2014 and Implications for the Pharmaceutical Industry
|
|
|
|
